Institution Information
Reportee Signature Date Report period Total Entries Total Value($)
SAMSARA BIOCAPITAL LLC 05-15-2019 03-31-2019 18 127,247,880,000
Institutional Holdings
Issuer Class Position Value Shares Portfolio Percentage (%) Previous Percentage (%) Shares Delta Shares Delta(%)
Intercept Pharmaceuticals Inc COM 1 $23,595,000 210,937 18.54 22.67 -23,438 -10.00
Allakos Inc COM 2 $18,100,000 446,905 14.22 23.00 -11,461 -2.50
Odonate Therapeutics Inc COM 3 $13,174,000 595,850 10.35 8.05 0 0.00
Principia Biopharma Inc COM 4 $13,038,000 383,480 10.25 10.08 0 0.00
Sutro BioPharma Inc COM 5 $12,820,000 1,125,579 10.07 9.74 3 0.00
Gossamer Bio Inc COM 6 $11,548,000 532,920 9.08 532,920 +Inf
Syros Pharmaceuticals Inc COM 7 $9,688,000 1,059,938 7.61 5.67 0 0.00
Liquidia Technologies Inc COM 8 $7,275,000 639,290 5.72 7.87 260,870 68.94
Sunesis Pharmaceuticals Inc COM 9 $4,556,000 3,750,000 3.58 3,750,000 +Inf
KalVista Pharmaceuticals Inc COM 10 $3,391,000 118,500 2.66 2.84 -31,500 -21.00
Aravive Inc COM 11 $3,117,000 442,733 2.45 1.50 0 0.00
Miragen Therapeutics Inc COM Liquidated $0 0 2.64 909,090 +Inf
Catabasis Pharmaceuticals Inc COM 13 $2,376,000 300,000 1.87 1.26 0 0.00
Evelo Biosciences Inc COM 14 $1,820,000 227,529 1.43 2.84 0 0.00
Urovant Sciences Ltd COM 15 $1,583,000 157,480 1.24 1.00 0 0.00
Millendo Therapeutics Inc COM 16 $677,000 45,101 0.53 0.34 0 0.00
Surface Oncology Inc COM 17 $373,000 78,300 0.29 0.32 0 0.00
PDS Biotechnology Corp COM 18 $68,000 9,166 0.05 9,166 +Inf
Edge Therapeutics Inc COM Liquidated $0 0 0.06 183,332 +Inf
Trillium Therapeutics Inc COM 20 $47,000 71,619 0.04 0.12 0 0.00
Debug Info- Version: 1.9